These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Codeine and opioid metabolism: implications and alternatives for pediatric pain management. Chidambaran V; Sadhasivam S; Mahmoud M Curr Opin Anaesthesiol; 2017 Jun; 30(3):349-356. PubMed ID: 28323671 [TBL] [Abstract][Full Text] [Related]
8. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Crews KR; Gaedigk A; Dunnenberger HM; Klein TE; Shen DD; Callaghan JT; Kharasch ED; Skaar TC; Clin Pharmacol Ther; 2012 Feb; 91(2):321-6. PubMed ID: 22205192 [TBL] [Abstract][Full Text] [Related]
9. The Use of Codeine and Tramadol in the Pediatric Population-What is the Verdict Now? Fortenberry M; Crowder J; So TY J Pediatr Health Care; 2019 Jan; 33(1):117-123. PubMed ID: 30545525 [TBL] [Abstract][Full Text] [Related]
10. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367 [TBL] [Abstract][Full Text] [Related]
11. Re: Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer [corrected]. de Wildt SN; Koren G Paediatr Anaesth; 2008 Mar; 18(3):273-4; author's reply 275-6. PubMed ID: 18230076 [No Abstract] [Full Text] [Related]
12. The pharmacogenetics of codeine hypoalgesia. Sindrup SH; Brøsen K Pharmacogenetics; 1995 Dec; 5(6):335-46. PubMed ID: 8845855 [TBL] [Abstract][Full Text] [Related]
13. A Single Site Population Study to Investigate CYP2D6 Phenotype of Patients with Persistent Non-Malignant Pain. Radford H; Simpson KH; Rogerson S; Johnson MI Medicina (Kaunas); 2019 May; 55(6):. PubMed ID: 31141989 [No Abstract] [Full Text] [Related]
14. Codeine for children: weighing the risks. Watt LD; Arnstein P Nursing; 2013 Nov; 43(11):62-3. PubMed ID: 24141588 [No Abstract] [Full Text] [Related]
15. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics. Zahari Z; Ismail R Drug Metab Pharmacokinet; 2014; 29(1):29-43. PubMed ID: 23759977 [TBL] [Abstract][Full Text] [Related]
16. Clinical application of pharmacogenetics in pain management. Smith DM; Weitzel KW; Cavallari LH; Elsey AR; Schmidt SO Per Med; 2018 Mar; 15(2):117-126. PubMed ID: 29714124 [TBL] [Abstract][Full Text] [Related]
17. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374 [TBL] [Abstract][Full Text] [Related]
18. CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids. Knisely MR; Carpenter JS; Draucker CB; Skaar T; Broome ME; Holmes AM; Von Ah D Appl Nurs Res; 2017 Dec; 38():107-110. PubMed ID: 29241501 [TBL] [Abstract][Full Text] [Related]
20. The effects of the genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone. Lurcott G Anesth Prog; 1998; 45(4):154-6. PubMed ID: 10483388 [No Abstract] [Full Text] [Related] [Next] [New Search]